β-Catenin inhibition shapes tumor immunity and synergizes with immunotherapy in colorectal cancer
In colorectal cancer, Wnt/β-catenin signaling is often aberrantly activated and associated with a T-cell-excluded phenotype which is a major obstacle for many immunotherapies. However, the effects of Wnt/β-catenin inhibition on tumor immunity and immunotherapy remain to be elucidated. In syngeneic m...
Main Authors: | Caihong Wang, Jingjing Yan, Pan Yin, Liming Gui, Lu Ji, Bin Ma, Wei-Qiang Gao |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2020-01-01
|
Series: | OncoImmunology |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/2162402X.2020.1809947 |
Similar Items
-
Wnt/β-Catenin Signaling and Immunotherapy Resistance: Lessons for the Treatment of Urothelial Carcinoma
by: Alexander Chehrazi-Raffle, et al.
Published: (2021-02-01) -
Sanguinarine suppresses migration and metastasis in colorectal carcinoma associated with the inversion of EMT through the Wnt/β‐catenin signaling
by: Man Zhu, et al.
Published: (2020-03-01) -
WDR74 promotes proliferation and metastasis in colorectal cancer cells through regulating the Wnt/β-catenin signaling pathway
by: Cai Zhou, et al.
Published: (2021-09-01) -
Extracellular vesicles containing oncogenic mutant β-catenin activate Wnt signalling pathway in the recipient cells
by: Hina Kalra, et al.
Published: (2019-12-01) -
(−)-Epigallocatechin-3-Gallate Inhibits Colorectal Cancer Stem Cells by Suppressing Wnt/β-Catenin Pathway
by: Yue Chen, et al.
Published: (2017-06-01)